Health Care & Life Sciences » Pharmaceuticals | Gujarat Themis Biosyn Ltd.

Gujarat Themis Biosyn Ltd. | Income Statement

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
302,303.40
314,401.90
326,246.90
355,870.90
387,999.00
410,499
Cost of Goods Sold (COGS) incl. D&A
231,035.30
241,027.70
263,715.80
290,877.20
296,570.00
310,076
Gross Income
71,268.10
73,374.20
62,531.10
64,993.70
91,429.00
100,423
SG&A Expense
10,664.90
12,187.80
12,198.80
13,715.90
40,522.00
39,312
EBIT
50,662.60
52,165.60
49,081.30
49,516.70
50,907.00
61,111
Unusual Expense
137.70
36.50
713.70
35.60
-
-
Non Operating Income/Expense
610.80
2,764.20
715.20
645.60
1,651.00
22,139
Interest Expense
6,648.30
3,872.00
3,774.50
3,532.20
4,177.00
1,296
Pretax Income
45,259.50
45,941.30
46,293.40
46,996.90
48,381.00
81,956
Income Tax
-
-
-
4,544.00
9,710.00
17,866
Consolidated Net Income
45,259.50
45,941.30
46,293.40
42,452.90
38,672.00
64,090
Net Income
45,259.50
45,941.30
46,293.40
42,452.90
38,672.00
64,090
Net Income After Extraordinaries
45,259.50
45,941.30
46,293.40
42,452.90
38,672.00
64,090
Net Income Available to Common
45,259.50
45,941.30
46,293.40
42,452.90
38,672.00
64,090
EPS (Basic)
3.12
3.16
3.19
2.92
2.66
4.41
Basic Shares Outstanding
14,528.70
14,528.70
14,528.70
14,528.70
-
-
EPS (Diluted)
3.12
3.16
3.19
2.92
-
-
Diluted Shares Outstanding
14,528.70
14,528.70
14,528.70
14,528.70
-
-
EBITDA
65,287.10
65,919.70
61,068.50
60,712.30
62,393.00
73,323
Other Operating Expense
9,940.60
9,020.80
1,251.00
1,761.20
-
-
Non-Operating Interest Income
772.10
448.40
985.20
402.40
-
-

About Gujarat Themis Biosyn

View Profile
Address
Themis House
Mumbai Maharashtra 400104
India
Employees -
Website http://www.gtbl.in
Updated 07/08/2019
Gujarat Themis Biosyn Ltd. is a pharmaceutical company, which engages in the manufacture of drugs. Its products include Rifamycin and Lovastatin. The company was founded on December 11, 1981 and is headquartered in Mumbai, India.